INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 19 filers reported holding INOTEK PHARMACEUTICALS CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $490,000 | -50.6% | 80,392 | -23.1% | 0.00% | 0.0% |
| Q3 2016 | $991,000 | +26.9% | 104,508 | -0.4% | 0.00% | 0.0% |
| Q2 2016 | $781,000 | +153.6% | 104,939 | +151.9% | 0.00% | – |
| Q1 2016 | $308,000 | -24.5% | 41,652 | +15.5% | 0.00% | -100.0% |
| Q4 2015 | $408,000 | +20.7% | 36,052 | +0.3% | 0.00% | – |
| Q3 2015 | $338,000 | +8350.0% | 35,955 | +4694.0% | 0.00% | – |
| Q2 2015 | $4,000 | -33.3% | 750 | -33.8% | 0.00% | – |
| Q1 2015 | $6,000 | – | 1,133 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|